Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry L Carter

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
JAMA|April 23, 2009
Equivalence of generic and brand-name drugs for cardiovascular diseaseBarry L Carter
Pharmacotherapy|July 27, 2010
Designing quality health services research: why comparative effectiveness studies are needed and why pharmacists should be involvedBarry L Carter
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISHBarry L Carter
Hypertension (Dallas, Tex. : 1979)|September 20, 2006
Antihypertensive prescribing: do we have reason to celebrate?Barry L Carter
Journal of Clinical Hypertension (Greenwich, Conn.)|April 27, 2012
Guidelines for use of diuretics: a view from a member of JNC 7Barry L Carter
Journal of Clinical Hypertension (Greenwich, Conn.)|February 19, 2009
Fixed-dosed combinations are not indicated as initial therapy: a debateBarry L Carter
Drugs & Aging|February 20, 2016
Evolution of Clinical Pharmacy in the USA and Future Directions for Patient CareBarry L Carter
Managed Care (Langhorne, Pa.)|September 16, 2003
Hypertension: a review of therapeutic optionsBarry L Carter
The Annals of Pharmacotherapy|January 31, 2002
Blood pressure as a surrogate end point for hypertensionBarry L Carter
Pharmacotherapy|March 3, 2016
Primary Care Physician-Pharmacist Collaborative Care Model: Strategies for ImplementationBarry L Carter
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
JAMA|April 23, 2009
Equivalence of generic and brand-name drugs for cardiovascular diseaseBarry L Carter
Pharmacotherapy|July 27, 2010
Designing quality health services research: why comparative effectiveness studies are needed and why pharmacists should be involvedBarry L Carter
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISHBarry L Carter
Hypertension (Dallas, Tex. : 1979)|September 20, 2006
Antihypertensive prescribing: do we have reason to celebrate?Barry L Carter
Journal of Clinical Hypertension (Greenwich, Conn.)|April 27, 2012
Guidelines for use of diuretics: a view from a member of JNC 7Barry L Carter
Journal of Clinical Hypertension (Greenwich, Conn.)|February 19, 2009
Fixed-dosed combinations are not indicated as initial therapy: a debateBarry L Carter
Drugs & Aging|February 20, 2016
Evolution of Clinical Pharmacy in the USA and Future Directions for Patient CareBarry L Carter
Managed Care (Langhorne, Pa.)|September 16, 2003
Hypertension: a review of therapeutic optionsBarry L Carter
The Annals of Pharmacotherapy|January 31, 2002
Blood pressure as a surrogate end point for hypertensionBarry L Carter
Pharmacotherapy|March 3, 2016
Primary Care Physician-Pharmacist Collaborative Care Model: Strategies for ImplementationBarry L Carter
Pageof 12